Showing results (541-550 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|April 17, 2020
Assessment of Therapy-Related Myeloid Neoplasms in Patients With Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy: A Systematic ReviewMohamad Bassam Sonbol, Thorvardur R Halfdanarson, Talal Hilal
JAMA Oncology|May 29, 2020
Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic EGFR-Mutant Lung Cancers: A Phase 1/2 Single-Group Open-Label TrialHelena A Yu, Adam J Schoenfeld, Alex Makhnin, et al.
JAMA Oncology|June 16, 2017
Genomic Profiling of Small-Bowel AdenocarcinomaAlexa B Schrock, Craig E Devoe, Robert McWilliams, et al.
JAMA Oncology|September 16, 2016
Changes in Antiemetic Overuse in Response to Choosing Wisely RecommendationsWilliam Encinosa, Amy J Davidoff
JAMA Oncology|May 1, 2018
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation CarriersJoanne Kotsopoulos, Jacek Gronwald, Beth Y Karlan, et al.
JAMA Oncology|May 1, 2018
Delays in the Publication of Important Clinical Trial Findings in OncologyLindor Qunaj, Raina H Jain, Coral L Atoria, et al.
JAMA Oncology|July 29, 2018
Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in ChildhoodAnna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, et al.
JAMA Oncology|August 12, 2018
Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric CancerXiangchun Li, Boris Pasche, Wei Zhang, et al.
JAMA Oncology|June 15, 2018
Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid TumorsAaron M Goodman, David Piccioni, Shumei Kato, et al.
JAMA Oncology|July 21, 2018
Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable CancersSkyler B Johnson, Henry S Park, Cary P Gross, et al.
Pageof 161